CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Tramadol",CYP2D6,Major – significant result that may require altering this medication
"Pantoprazole (Tecta)",CYP2C19,"Minor – result should be considered as may affect medicationresponse"
"Vortioxetine(Brintellix)",CYP2D6,"Minor – result should be considered as may affect medicationresponse"
"Gliclazide (Diamicron60Mg MR)","CYP2C19CYP2C9",Usual prescribing considerations apply
"Irbesartan",CYP2C9,Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
"salbutamol, insulin (Hypurin Isophane (NPH)), furosemide (Furosemide Tablets), levothyroxine sodium(Levothyroxine Sodium For Injection), aspirin, folic acid, insulin / insulin (Humalog), pancreatic extract bp (Creon),lorazepam (Ativan)",,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,Altered response,DPWG1
"Antidepressants -SSRIs",Fluvoxamine,"CYP2D6CYP1A2",Reduced / inadequate response,CPIC2
"",Paroxetine,CYP2D6,Reduced / inadequate response,CPIC2
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Altered response,CPIC3
"",Clomipramine,"CYP2D6CYP2C19",Altered response,CPIC3
"",Desipramine,CYP2D6,Reduced / inadequate response,CPIC3
"",Doxepin,"CYP2D6CYP2C19",Altered response,CPIC3
"",Imipramine,"CYP2D6CYP2C19",Altered response,CPIC3
"",Nortriptyline,CYP2D6,Reduced / inadequate response,CPIC3
Antiemetics,Ondansetron,CYP2D6,Reduced / inadequate response,CPIC4
Beta blockers,Metoprolol,CYP2D6,Reduced / inadequate response,DPWG1
Miscellaneous,Eliglustat,CYP2D6,Reduced / inadequate response,TGA5
Opioid Analgesics,Codeine,"CYP2D6OPRM1",Adverse effects,CPIC6
Hydrocodone,CYP2D6,Adverse effects,,
Oxycodone,CYP2D6,Adverse effects,DPWG1,
Tramadol,CYP2D6,Adverse effects,DPWG1,
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Reduced / inadequate response,-
Antiarrhythmics,Flecainide,CYP2D6,Reduced / inadequate response,DPWG1
"",Propafenone,CYP2D6,Reduced / inadequate response,DPWG1
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,Reduced / inadequate response,-
"",Fesoterodine,CYP2D6,Reduced / inadequate response,-
"",Tolterodine,CYP2D6,Reduced / inadequate response,-
Anticholinesterases,Donepezil,CYP2D6,Reduced / inadequate response,-
"",Galantamine,CYP2D6,Reduced / inadequate response,-
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Increased acenocoumarolsensitivity",
"",Warfarin,"VKORC1CYP2C9",Increased warfarin sensitivity,FDA7
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Reduced / inadequate response,-
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Vortioxetine,CYP2D6,Reduced / inadequate response,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Reduced / inadequate response,-
"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9",Altered response,-
Antiemetics,Metoclopramide,CYP2D6,Reduced / inadequate response,-
Antihistamines,Chlorpheniramine,CYP2D6,Altered response,-
"",Dexchlorpheniramine,CYP2D6,Altered response,-
"",Promethazine,CYP2D6,Reduced / inadequate response,-
Antipsychotics,Aripiprazole,CYP2D6,Reduced / inadequate response,-
"",Brexpiprazole,CYP2D6,Reduced / inadequate response,-
"",Chlorpromazine,CYP2D6,Reduced / inadequate response,-
"",Haloperidol,CYP2D6,Reduced / inadequate response,DPWG
"",Pimozide,CYP2D6,Reduced / inadequate response,
"",Risperidone,CYP2D6,Altered response,DPWG1
"",Zuclopenthixol,CYP2D6,Reduced / inadequate response,DPWG1
Antitussives,Dextromethorphan,CYP2D6,Altered response,-
Beta blockers,Carvedilol,CYP2D6,Reduced / inadequate response,-
"",Nebivolol,CYP2D6,Reduced / inadequate response,-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC8
Miscellaneous,Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
Neurological drugs,Tetrabenazine,CYP2D6,Reduced / inadequate response,-
Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
"",Esomeprazole,CYP2C19,Reduced / inadequate response,-
"",Lansoprazole,CYP2C19,Reduced / inadequate response,-
"",Omeprazole,CYP2C19,Reduced / inadequate response,-
"",Pantoprazole,CYP2C19,Reduced / inadequate response,-
"",Rabeprazole,CYP2C19,Reduced / inadequate response,-
Psychostimulants,Dextroamphetamine,CYP2D6,Reduced / inadequate response,-
Lisdexamfetamine,CYP2D6,Reduced / inadequate response,-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
"Antidepressants -other",Moclobemide,CYP2C19,"No altered effect predicted bygenotype",-
"Antidepressants -SSRIs",Citalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC2
Escitalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC2,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Sertraline,CYP2C19,"No altered effect predicted bygenotype",CPIC2
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","No altered effect predicted bygenotype",-
"",Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC9
Antifungals - Azoles,Voriconazole,CYP2C19,"No altered effect predicted bygenotype",CPIC10
Antiplatelet drugs,Clopidogrel,CYP2C19,"No altered effect predicted bygenotype",CPIC11
Antipsychotics,Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
Benzodiazepines,Clobazam,CYP2C19,"No altered effect predicted bygenotype",-
"",Diazepam,CYP2C19,"No altered effect predicted bygenotype",-
Beta blockers,Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC12
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Cyclophosphamide,CYP2C19,"No altered effect predicted bygenotype",-
"",Proguanil,CYP2C19,"No altered effect predicted bygenotype",-
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-,
Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-,
Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-,
Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-,
Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-,
Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-,
Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Statins,Atorvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",-
Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-,
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Simvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",CPIC13,
